Tags

Type your tag names separated by a space and hit enter

MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
AJR Am J Roentgenol. 2003 Apr; 180(4):901-10.AA

Abstract

OBJECTIVE

The purpose of this study was to review MR imaging findings in the ipsilateral breast in women with percutaneously proven breast cancer.

MATERIALS AND METHODS

Retrospective review was performed of records of 70 consecutive women with percutaneously proven unilateral breast cancer who were considered candidates for breast conservation surgery and who had preoperative MR imaging of the ipsilateral breast. MR images and medical records were reviewed.

RESULTS

MR imaging identified mammographically and clinically occult cancer other than the index lesion in the ipsilateral breast in 19 women (27%), including infiltrating cancer in 11 women (16%) and ductal carcinoma in situ in eight women (11%). These additional sites of cancer were in the same quadrant as the index cancer in 14 women (20%), in a different quadrant in three women (4%), and in both the same and different quadrants in two women (3%). Additional sites of cancer were more likely in women with, rather than in those without, a family history of breast cancer (42% vs 14%, p < 0.02) and in women whose index cancer was infiltrating lobular rather than other histologies (55% vs 22%, p < 0.06). In 17 women (24%), MR imaging detected ipsilateral lesions that were benign. Changes due to prior percutaneous biopsy were infrequently observed on MR images and included a clip in 12 women (17%) and a small hematoma in two women (3%).

CONCLUSION

MR imaging identified additional sites of ipsilateral cancer in 27% of women with percutaneously proven breast cancer. The yield was highest in women with a family history of breast cancer or infiltrating lobular histology in the index cancer. Change after biopsy was infrequent and did not interfere with the MR imaging interpretation.

Authors+Show Affiliations

Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Evaluation Study
Journal Article

Language

eng

PubMed ID

12646427

Citation

Liberman, Laura, et al. "MR Imaging of the Ipsilateral Breast in Women With Percutaneously Proven Breast Cancer." AJR. American Journal of Roentgenology, vol. 180, no. 4, 2003, pp. 901-10.
Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003;180(4):901-10.
Liberman, L., Morris, E. A., Dershaw, D. D., Abramson, A. F., & Tan, L. K. (2003). MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR. American Journal of Roentgenology, 180(4), 901-10.
Liberman L, et al. MR Imaging of the Ipsilateral Breast in Women With Percutaneously Proven Breast Cancer. AJR Am J Roentgenol. 2003;180(4):901-10. PubMed PMID: 12646427.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AU - Liberman,Laura, AU - Morris,Elizabeth A, AU - Dershaw,D David, AU - Abramson,Andrea F, AU - Tan,Lee K, PY - 2003/3/21/pubmed PY - 2003/5/6/medline PY - 2003/3/21/entrez SP - 901 EP - 10 JF - AJR. American journal of roentgenology JO - AJR Am J Roentgenol VL - 180 IS - 4 N2 - OBJECTIVE: The purpose of this study was to review MR imaging findings in the ipsilateral breast in women with percutaneously proven breast cancer. MATERIALS AND METHODS: Retrospective review was performed of records of 70 consecutive women with percutaneously proven unilateral breast cancer who were considered candidates for breast conservation surgery and who had preoperative MR imaging of the ipsilateral breast. MR images and medical records were reviewed. RESULTS: MR imaging identified mammographically and clinically occult cancer other than the index lesion in the ipsilateral breast in 19 women (27%), including infiltrating cancer in 11 women (16%) and ductal carcinoma in situ in eight women (11%). These additional sites of cancer were in the same quadrant as the index cancer in 14 women (20%), in a different quadrant in three women (4%), and in both the same and different quadrants in two women (3%). Additional sites of cancer were more likely in women with, rather than in those without, a family history of breast cancer (42% vs 14%, p < 0.02) and in women whose index cancer was infiltrating lobular rather than other histologies (55% vs 22%, p < 0.06). In 17 women (24%), MR imaging detected ipsilateral lesions that were benign. Changes due to prior percutaneous biopsy were infrequently observed on MR images and included a clip in 12 women (17%) and a small hematoma in two women (3%). CONCLUSION: MR imaging identified additional sites of ipsilateral cancer in 27% of women with percutaneously proven breast cancer. The yield was highest in women with a family history of breast cancer or infiltrating lobular histology in the index cancer. Change after biopsy was infrequent and did not interfere with the MR imaging interpretation. SN - 0361-803X UR - https://www.unboundmedicine.com/medline/citation/12646427/MR_imaging_of_the_ipsilateral_breast_in_women_with_percutaneously_proven_breast_cancer_ L2 - https://www.ajronline.org/doi/10.2214/ajr.180.4.1800901 DB - PRIME DP - Unbound Medicine ER -